[go: up one dir, main page]

RU2018131821A3 - - Google Patents

Download PDF

Info

Publication number
RU2018131821A3
RU2018131821A3 RU2018131821A RU2018131821A RU2018131821A3 RU 2018131821 A3 RU2018131821 A3 RU 2018131821A3 RU 2018131821 A RU2018131821 A RU 2018131821A RU 2018131821 A RU2018131821 A RU 2018131821A RU 2018131821 A3 RU2018131821 A3 RU 2018131821A3
Authority
RU
Russia
Application number
RU2018131821A
Other versions
RU2018131821A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018131821A publication Critical patent/RU2018131821A/ru
Publication of RU2018131821A3 publication Critical patent/RU2018131821A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2018131821A 2016-02-10 2017-02-10 Композиции и их применения RU2018131821A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1602409.3A GB201602409D0 (en) 2016-02-10 2016-02-10 Compositions and uses thereof
GB1602409.3 2016-02-10
PCT/GB2017/050343 WO2017137761A1 (en) 2016-02-10 2017-02-10 Compositions and uses thereof

Publications (2)

Publication Number Publication Date
RU2018131821A RU2018131821A (ru) 2020-03-10
RU2018131821A3 true RU2018131821A3 (ru) 2020-12-04

Family

ID=55642116

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018131821A RU2018131821A (ru) 2016-02-10 2017-02-10 Композиции и их применения

Country Status (9)

Country Link
US (1) US20190046600A1 (ru)
EP (1) EP3414326A1 (ru)
JP (1) JP2019512462A (ru)
CN (1) CN109790523A (ru)
AU (1) AU2017217330A1 (ru)
CA (1) CA3012239A1 (ru)
GB (1) GB201602409D0 (ru)
RU (1) RU2018131821A (ru)
WO (1) WO2017137761A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2582571B (en) * 2019-03-25 2024-02-28 Syntherix Ltd Peptides and use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9721367D0 (en) 1997-10-09 1997-12-10 Univ Liverpool Delivery system
WO2000026228A1 (en) 1998-11-02 2000-05-11 Clontech Laboratories, Inc. Gene and protein for regulation of cell death
GB0001481D0 (en) 2000-01-21 2000-03-15 Theryte Ltd System for delivering a medicament
EP1349555A4 (en) * 2000-12-04 2007-04-25 Sloan Kettering Inst Cancer TREATMENT OF CANCER BY REDUCING INTRACELLULAR ENERGY AND USING PYRIMIDINES
WO2006078503A2 (en) 2005-01-07 2006-07-27 Arqule, Inc. Compositions for modulation of parp and methods for screening for same
US8080517B2 (en) 2005-09-12 2011-12-20 Xigen Sa Cell-permeable peptide inhibitors of the JNK signal transduction pathway
GB0804496D0 (en) 2008-03-11 2008-04-16 Theryte Ltd Treating cancer
CA2878094A1 (en) * 2012-06-27 2014-01-03 Siscapa Assay Technologies, Inc. Multipurpose mass spectrometric assay panels for peptides
EP2904004B1 (en) * 2012-10-04 2018-11-21 Research Development Foundation Serine protease molecules and therapies
GB2530479A (en) * 2014-08-06 2016-03-30 Hilmar Meek Warenius Peptides useful for treating cancer

Also Published As

Publication number Publication date
CN109790523A (zh) 2019-05-21
US20190046600A1 (en) 2019-02-14
AU2017217330A1 (en) 2018-08-09
EP3414326A1 (en) 2018-12-19
JP2019512462A (ja) 2019-05-16
CA3012239A1 (en) 2017-08-17
GB201602409D0 (en) 2016-03-23
WO2017137761A1 (en) 2017-08-17
RU2018131821A (ru) 2020-03-10
AU2017217330A8 (en) 2018-08-30

Similar Documents

Publication Publication Date Title
BR112019001667A2 (ru)
BR122021017409A2 (ru)
BR112018003417A2 (ru)
BR112019002665A2 (ru)
BR112019009366A2 (ru)
BR112019009203A2 (ru)
RU2018131821A3 (ru)
BR202016030146U2 (ru)
CN303548289S (ru)
CN303539396S (ru)
CN303535548S (ru)
CN303725621S (ru)
CN303714684S (ru)
CN303670322S (ru)
CN303652915S (ru)
CN303535879S (ru)
CN303628609S (ru)
CN303610822S (ru)
CN303589852S (ru)
CN303589719S (ru)
CN303580010S (ru)
CN303572006S (ru)
CN303535882S (ru)
CN303564043S (ru)
CN303538528S (ru)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20210426